Here are five highlights.
1. This full U.S. launch follows the company’s alpha introduction of the technology in certain market areas.
2. So far, Titan Spine has sold nanoLOCK implants in 14 hospitals in eight states.
3. The company is currently undergoing contract processes with a few larger hospital systems.
4. In October 2016, CMS created a new technology category and code for the nanoLOCK technology.
5. The FDA cleared the technology in 2014.
More articles on devices:
35 spine, orthopedic devices receive FD A 510(k) clearance in September 2016
SpineGuard reports €1.7M Q3 2016 revenue — 6 notes
5 observations on how 3D printing is transforming the medical device industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
